LSI USA '25 Almost at Capacity: Register Today arrow-icon

Overview

Valued at ~$1.69 billion in 2023, the peripheral vascular and biliary stents market is projected to reach ~$2.24 billion by 2028, increasing at a CAGR of 5.9% over the 2023-2028 forecast period. This Market Snapshot is part of LSI’s Market Intelligence platform, your one-stop-shop for global medtech market sizing and analysis, procedure volume data, startup company- and deal-tracking, curated insights, and more.
Peripheral vascular and biliary stents are medical devices designed to maintain the patency of anatomical vessels or ducts. A peripheral vascular stent is typically inserted during a percutaneous transluminal angioplasty (PTA) or other revascularization procedures to treat stenosed blood vessels and restore proper blood flow. In contrast, a biliary stent is a thin, tube-like device placed to support a narrowed section of the bile duct, preventing the reformation of a stricture or providing palliative relief for malignancies in the biliary tract. Biliary stents are commonly placed using endoscopic retrograde cholangiopancreatography (ERCP) or percutaneous transhepatic cholangiography (PTC).
Products included within the scope of this analysis include:
Biliary stents
Iliac artery stents
Peripheral vascular stents
This Market Snapshot is intended to provide a high-level overview of the global market for peripheral vascular and biliary stents, with key insights into:
Unit volumes from 2023 to 2028
Market forecasts from 2023 to 2028
Market insights
Competitive landscape analysis of major competitors
Insights into key market events for strategic and startups

Peripheral Vascular and Biliary Stents Market Snapshot Summary

Snapshot Aspect Data and Details
Base Year for Estimate 2023
Forecast Period 2023 - 2028
Market Size in 2023 $1.69 billion
CAGR 5.9%
Projected Market Size in 2028 $2.24 billion

Peripheral Vascular and Biliary Stents Market Insights

The peripheral vascular and biliary stents market is experiencing steady growth, driven by the rising prevalence of peripheral vascular disease and the increasing use of advanced stent technologies. While stents, including drug-eluting types, have seen some decline due to the rise of drug-coated balloons, the market is expected to grow with the introduction of bioresorbable stents. These innovative devices are anticipated to offer improved clinical outcomes for patients with severe peripheral artery disease.
Bioresorbable stents, such as Abbott’s Esprit, provide short-term support to diseased vessels, enhancing vessel patency and reducing the risk of complications like stent fractures. As these technologies continue to develop, they are expected to drive growth in both unit and dollar volume for the stents market, particularly in the latter years of the forecast period.

Competitive Landscape

The full Market Snapshot includes a robust analysis of the competitive landscape for the peripheral vascular and biliary stents market. This includes estimated market revenue and market share for key players, such as Boston Scientific, BD, and Cordis.
Peripheral vascular and biliary stents market competitor breakdown.

Select Market Events

Company Date Type Event
Abbott
4/2024 Regulatory Approval Abbott received U.S. FDA clearance for its Esprit BTK Everolimus Eluting Resorbable Scaffold System in arteries below the knee.
Cordis
11/2023 Clinical Study Cordis announced the end of patient enrollment in its RADIANCY premarket clinical study in pursuance of CE mark approval for its SMART Radianz vascular stent system.

Key Companies Covered

Abbott
BIOTRONIK
Boston Medical
Boston Scientific
Bryan Medical
Cordis
Hood Labs
Maquet
Merit Medical
MicroPort Scientific
Olympus
W.L. Gore

Order individually or subscribe and
get a complete intel platform.

Trusted By The Companies Pioneering What’s Next